Upload
dr-krishna-koirala
View
6
Download
0
Embed Size (px)
Citation preview
Neoplasms of the oral cavity
Dr. Krishna Koirala
19/12/2016; 2:15 PM
Subsites of the oral cavity • Lips• Buccal mucosa• Retromolar trigone • Gingiva• Hard palate • Anterior two-thirds
of
the tongue• Floor of mouth
Benign neoplasms• Fibroma • Papilloma• Peripheral giant cell granuloma• Pyogenic granuloma
• Lipoma• Hemangioma• Lymphangioma
Malignant neoplasms• Squamous cell carcinoma (90%)• Verrucous carcinoma• Minor salivary gland tumors (5%)• Melanoma• Lymphoma• Sarcoma
2-5%
Risk factors
• Tobacco : Smoking , Chewing tobacco (>90% )
• Alcohol• Diet and nutrition : – Deficiencies of vit A, C, E, Iron, selenium,
folate
• Viruses: HPV, EBV,HSV (role unclear )• Oral hygiene : Poor oral hygiene, ill
fitting dentures• Premalignant conditions : Leukoplakia,
erythroplakia• Others : sepsis, spices, sharp tooth
Clinical presentation• A red lesion ,white or mixed white and red
lesion• An ulcer with fissuring or raised exophytic
margins• An indurated lump (firm infiltration
beneath the mucosa)• A nonhealing extraction socket• A lesion fixed to deeper tissues or to
overlying skin or mucosa• Cervical lymph node enlargement
(infection, reactive hyperplasia 20 to tumor , or metastatic disease)
Screening of oral cancer• The VELscope device– The VELscope Hand piece emits a safe
blue light into the oral cavity, which excites the tissue from the surface of the epithelium to the basement membrane and into the stroma causing it to fluoresce
– The clinician is then able to immediately view the different fluorescence responses to help differentiate between normal and abnormal tissue
• Healthy tissue appears as a bright apple-green glow • Suspicious regions are identified by a loss of fluorescence, which thus appear dark
OraScan, OraScreen , ‘OraTest’ • Tolonium chloride or toluidine blue (TB) is an
acidophilic metachromatic dye of the thiazine group that preferentially stains nucleic acids and abnormal tissues
• The increased nuclear density and the loss of intracellular adherence in dysplastic and malignant tissues allows TB dye to penetrate through the epithelium and be retained in these tissues, thereby staining these areas of abnormality as blue
Chemiluminescent illumination positivity
Toluidine blue positivity
Investigations• Incisional biopsy– Essential to confirm the diagnosis– Biopsy must be performed on any oral
mucosal lesion suggestive of cancer, including any ulcer that does not heal within 2-3 weeks
– In vivo staining with toluidine blue followed by a rinse with 1% acetic acid and then saline may stain the areas most appropriate for the biopsy if widespread lesions are present
Imaging studies• B wave USG : Helpful in assessing the depth
of invasion in oral tongue • MRI : Imaging mode of choice for soft tissue
lesions of oral cavity • CT scan : Bone invasion• Orthopantomogram (OPG) : To assess the
state of dentition and potential gross mandibular invasion
• Technetium Bone scan : mandibular invasion
CT scan of mandible
UICC/AJCC Staging system for oral cancer
• Primary Tumor (T) – TX : Primary tumor cannot be assessed – T0 : No evidence of primary tumor – Tis : Carcinoma in situ – T1: Tumor 2 cm or less in greatest dimension – T2 : Tumor >2 cm but < 4 cm in greatest dimension – T3 : Tumor more than 4 cm in greatest dimension– T4 : Tumor invades adjacent structures (eg,
through cortical bone, into deep muscles of tongue, maxillary sinus, skin)
• Regional Lymph Nodes (N)
–NX : Regional lymph nodes cannot be
assessed
–N0 : No regional lymph node
metastasis
–N1 : Metastasis in a single
ipsilateral lymph node , 3 cm
or less in greatest dimension
• N2:
– N2a : Metastasis in single ipsilateral lymph
node more than 3 cm but not more than 6 cm
in greatest dimension
– N2b : Metastasis in multiple ipsilateral
lymph nodes, none more than 6 cm in
greatest dimension
– N2c : Metastasis in bilateral or
contralateral lymph nodes, none more than 6
cm in greatest dimension• N3 : Metastasis in a lymph node more than 6
cm in greatest dimension
• Distant Metastasis (M) –MX : Presence of distant metastasis
cannot be assessed –M0 : No distant metastasis –M1 : Presence of distant metastasis
Staging of oral cancerStage I T1, N0, M0
Stage II T2, N0, M0
Stage III T3, N0, M0T1, T2, T3, N1, M0
Stage IV T4, N0, M0
Any T, N2 or N3, M0
Any T, any N, any M
Management of cancer of oral tongue according to tumor
thicknessTumor Thickness
Recommended management
< 3 mm Partial glossectomy alone
4-9 mm Partial glossectomy +/- Elective ipsilateral level I - IV , selective neck dissection
> 10 mm Partial glossectomy, neck dissection and post operative Radiotherapy tom primary site and neck
• Management of Stage I – II oral tongue carcinoma – Transoral resection and primary closure • Wide local resection with at least 1.5 cm margin• Partial glossectomy• Hemiglossectomy
– Brachytherapy– Curative radiotherapy• 66 -74 Gy (2.0 Gy/fraction; Sunday-Thursday in 7wk)
• May be used with adequate results
Wide local excision of tongue carcinoma
• Management of Stage III - IV oral tongue cancer– Partial to subtotal glossectomy
– Ipsilateral selective level I- IV resection for N 0 Neck
– Modified radical neck dissection type III for N positive neck
– Commando operation (composite resection) : Combined mandibulectomy and neck dissection ( removal of the primary tumor along with a segment of the mandible, and ipsilateral neck dissection all as one continuous block for FOM tumors involving the mandible)
– Postoperative radiotherapy of oral cavity and neck (66 -74 Gy (2.0 Gy/fraction; Sunday-Thursday in 7wk)
Classification of Tongue Defects
• Oral Hemiglossectomy : Hemiresection of the oral tongue with resection of less than half of the base of tongue
• Hemiglossectomy : Hemiresection of the whole tongue
• Subtotal or total oral glossectomy – Subtotal or total resection of the oral tongue
with resection of less than half of the base of the tongue
• Subtotal glossectomy : Subtotal resection of the whole tongue
• Total glossectomy– Total resection of the whole tongue
Classification of Tongue Defects
Reconstruction techniques in oral cancers
• Aim– Mucosal resurfacing and replacement of tongue
volume• Techniques– Pectoralis major myocutaneous flaps ( Poor tongue
mobility, bulk )– Local muscle flaps e.g. masseter and cutaneous flaps– Free radial forearm fasciocutaneous flap– Anterolateral thigh flap ( greater soft tissue volume
to improve swallowing function)
Reconstruction by using PMMC flap
Free radial forearm flap for tongue reconstruction
Reconstruction of oncological oro -mandibular defects with double skin paddled - free fibula flap
Chemoradiation in oral cavity cancers
• Radiotherapy
– Larger lesions where excision would
compromise speech and swallowing
ability
• Combined modality therapy of surgery,
radiation therapy and chemotherapy
– Patients with local or regionally
advanced disease
• Concomitant chemotherapy (with 5 - Fluorouracil and cisplatin) and radiation therapy – Most effective sequencing of treatment – Drugs with single agent activity in this setting
include methotrexate, 5FU, cisplatin, paclitaxel, docetaxel
– Combinations of carboplatin and 5FU, and cisplatin and paclitaxel are also used
• Palliative intent – Patients with recurrent and/or metastatic disease
• Rehabilitation